2-(2-Chloro-ethyl)-5-fluoro-isoindole-1,3-dione, 95.0%, 250mg

2-Bromobenzohydrazide>98.0%(GC)(T)5g

4-(benzyloxy)-5-methoxy-2-nitrobenzaldehyde, 95.0%, 10g

6-Amidino-2-naphthol Methanesulfonate>99.0%(HPLC)(T)1g

2-(3-Bromonaphthalen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 250mg

1-CYCLOBUTYLETHAN-1-ONE, 95.0%, 1g

4-[2-(4-chlorophenyl)acetyl]-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

trans-Methyl 2-[4-[4-[(trifluoromethylsulfonyl)oxy]phenyl]cyclohexyl]acetate, 95%, 1g

1-(2-Methoxyphenyl)-4-(2-nitrophenyl)piperazine, 97%, 1g

N-(Chloroacetoxy)succinimide, 95.0%, 1g

3-Phenylcyclopentanol, 97%, 500mg

Ethyl 3-(Trifluoromethyl)phenoxyacetate>95.0%(GC)1g

(R)-(+)-2-Metil-2-propanosulfinamida, mínimo 97 %, 5 g, envase de vidrio